Quantitative Systematic Strategies’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-33,417
Closed -$322K 146
2021
Q2
$322K Buy
33,417
+13,463
+67% +$131K 0.11% 319
2021
Q1
$197K Sell
19,954
-4,462
-18% -$69.1K 0.03% 570
2020
Q4
$564K Buy
24,416
+1,903
+8% +$38.9K 0.08% 367
2020
Q3
$318K Buy
+22,513
New +$328K 0.06% 424
2020
Q1
Sell
-81,931
Closed -$798K 357
2019
Q4
$798K Buy
81,931
+18,307
+29% +$168K 0.12% 260
2019
Q3
$510K Sell
63,624
-2,908
-4% -$31.6K 0.12% 231
2019
Q2
$830K Buy
66,532
+38,608
+138% +$490K 0.16% 182
2019
Q1
$380K Buy
27,924
+2,283
+9% +$27.9K 0.09% 231
2018
Q4
$246K Buy
+25,641
New +$282K 0.06% 466
2018
Q3
Sell
-11,478
Closed -$179K 681
2018
Q2
$179K Buy
+11,478
New +$174K 0.03% 563
2017
Q4
Sell
-11,117
Closed -$168K 584
2017
Q3
$168K Buy
11,117
+140
+1% +$1.85K 0.04% 412
2017
Q2
$109K Sell
10,977
-2,479
-18% -$19.9K 0.03% 420
2017
Q1
$96K Buy
+13,456
New +$85.1K 0.03% 346
2016
Q1
Sell
-104,059
Closed -$1M 543
2015
Q4
$1M Buy
+104,059
New +$938K 0.27% 52
2015
Q3
Sell
-44,021
Closed -$613K 421
2015
Q2
$613K Buy
44,021
+13,012
+42% +$156K 0.14% 246
2015
Q1
$340K Sell
31,009
-4,344
-12% -$38.3K 0.09% 332
2014
Q4
$294K Buy
35,353
+13,215
+60% +$90.7K 0.12% 232
2014
Q3
$133K Buy
+22,138
New +$116K 0.08% 284

Other funds holding FOLD

Quantitative Systematic Strategies's FOLD Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Amicus Therapeutics (FOLD) in Q3 2021, closing a stake of 33,417 shares — an estimated $322K sold.

Quantitative Systematic Strategies first reported a position in FOLD in Q3 2014 and held it in 18 quarters. The position peaked at $1M in Q4 2015. 236 funds tracked by Wall St. Rank hold FOLD as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Amicus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 33,417 Amicus Therapeutics shares in Q3 2021, an estimated $322K.
  • Quantitative Systematic Strategies first reported a position in Amicus Therapeutics in Q3 2014 and held it in 18 quarters.
  • Quantitative Systematic Strategies's Amicus Therapeutics position peaked at $1M in Q4 2015.
  • 236 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.